[Is subclinical hypothyroidism a cardiovascular risk factor?].

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Internal Medicine

Context:

• Subclinical hypothyroidism (elevated TSH, normal free T4) is common but its health impacts and treatment benefits are debated.
• Existing research explores the link between subclinical hypothyroidism and cardiovascular disease (CVD).

Purpose:

• To evaluate the consequences of subclinical hypothyroidism on cardiovascular health.
• To assess the potential benefits of thyroxine supplementation in managing subclinical hypothyroidism and associated cardiovascular risks.

Summary:

• Subclinical hypothyroidism can cause subtle cardiac dysfunction and increased peripheral vascular resistance.
• Mild elevations in LDL-cholesterol are associated with subclinical hypothyroidism, potentially reversible with treatment.
• Evidence is insufficient to classify subclinical hypothyroidism as an independent CVD risk factor.

Impact:

• Treatment with thyroxine may partially reverse cardiac and vascular abnormalities associated with subclinical hypothyroidism.
• Consideration of treatment for individuals with TSH levels at or near 10 mU/l is suggested for potential CVD prevention.
• Euthyroidism restoration may be beneficial for patients with TSH levels exceeding 10 mU/l, based on observational and interventional data.